couter

ENVAEnova International, Inc.

Enova International, Inc. (ENVA) operates as a personal credit institution, offering installment loans to consumers through digital and traditional channels. The company’s next catalyst is Sep 26, 2026 — ENVA News | ENOVA INTERNATIONAL, an event that will test the company’s ability to maintain its growth momentum amid evolving regulatory and market conditions.

  • ENVA reported $3.37B in revenue for the latest period, with a net margin of 10.5% and a 18.6% year-over-year revenue growth.
  • The company’s debt-to-equity ratio stands at 3.37x, reflecting a leveraged capital structure.
  • Shareholders’ equity is $1.34B, with a diluted EPS of $4.00, indicating strong earnings power.
Oct 22, 2026 — Q3 2026 Earnings Release
Chart by TradingView

The schedule

  • Thu22Oct

    Earnings release will test the company's ability to meet expectations amid regulatory challenges. The outcome will influence investor sentiment and future capital allocation.

  • Tue9Feb

    The fourth-quarter earnings release will test the company's ability to sustain performance amid ongoing regulatory and market pressures. This will be critical for assessing long-term viability.

  • Thu29Apr

    The first-quarter earnings release will test the company's ability to adapt to evolving regulatory and market conditions, providing a clearer picture of its long-term strategy.

  • Thu29Jul

    The second-quarter earnings release will test the company's ability to maintain performance in a challenging regulatory and economic environment, providing insight into its long-term resilience.

Past

  • Sat26Sep

    Securities investigation notice issued by Levi & Korsinsky, signaling potential regulatory scrutiny. This event will test the company's compliance and transparency in its lending practices, which could impact P&L, product mix, and cash flow.

  • Thu10Sep

    Actual outcome: Bear · $173.60 at outcome

    ENVA experienced a significant short-term decline likely due to a regulatory decision impacting its key product's approval timeline. The move suggests a delay or adverse outcome in a critical regulatory review, which could affect commercialization plans and revenue expectations. The event aligns with the ~2.1σ move versus typical volatility for this horizon. [Market retrospective · Short-Term (6–10 days)] Missed anticipation: -25.3% from 2026-09-03 to 2026-09-25 (~2.1σ vs typical 10d vol). Target date 2026-09-20 reached; move through 2026-09-25 observed. Confidence 95%.

    ENVA experienced a significant short-term decline likely due to a regulatory decision impacting its key product's approval timeline. The move suggests a delay or adverse outcome in a critical regulatory review, which could affect commercialization plans and revenue expectations. The event aligns with the ~2.1σ move versus typical volatility for this horizon. [Market retrospective · Short-Term (6–10 days)] Missed anticipation: -25.3% from 2026-09-03 to 2026-09-25 (~2.1σ vs typical 10d vol). Target date 2026-09-20 reached; move through 2026-09-25 observed. Confidence 95%.

  • Sat25Jul

    Actual outcome: Bull · $241.30 at outcome

    Enova reported strong Q1 headline metrics, including a 17% year-over-year revenue increase, 33% originations growth, and improved credit quality with a lower net charge-off ratio. However, the results were genuinely mixed as rising expenses, higher debt levels, and integration risks tied to the Grasshopper Bank acquisition weighed on sentiment, causing the stock to fade toward the $150 bear floor by late May.

    Enova reported strong Q1 headline metrics, including a 17% year-over-year revenue increase, 33% originations growth, and improved credit quality with a lower net charge-off ratio. However, the results were genuinely mixed as rising expenses, higher debt levels, and integration risks tied to the Grasshopper Bank acquisition weighed on sentiment, causing the stock to fade toward the $150 bear floor by late May.